News | Akroswiss

Akroswiss takes a step forward in the interest of patients closing a multi-million CHF funding round

ZUG, Switzerland: May 17, 2021 Akroswiss is developing an innovative and patented Midazolam-based nasal spray to treat patients suffering...

marcfroehlich

May 17, 20212 min read